PHD-BIOE-L Archives

September 2016

PHD-BIOE-L@LISTSERV.GMU.EDU

Options: Use Proportional Font
Show HTML Part by Default
Show All Mail Headers

Message: [<< First] [< Prev] [Next >] [Last >>]
Topic: [<< First] [< Prev] [Next >] [Last >>]
Author: [<< First] [< Prev] [Next >] [Last >>]

Print Reply
Subject:
From:
Claudia Borke <[log in to unmask]>
Reply To:
Claudia Borke <[log in to unmask]>
Date:
Mon, 26 Sep 2016 16:16:03 +0000
Content-Type:
multipart/related
Parts/Attachments:
text/plain (8 kB) , text/html (11 kB) , image001.jpg (8 kB) , image002.jpg (8 kB)
Dear Bioengineering Students,

Bring and your family and friends to enjoy a fun night of science and learn about groundbreaking breast cancer research.

Galileo’s Science Café

October 6th 7:00pm-8:30pm (Doors open at 6:00pm)

Location: Hylton Performing Arts Center, 10960 George Mason Circle, Manassas, VA

Attendance to this event is FREE.  Free appetizers and a cash bar available.

Space is limited!  RSVP to attend the October 6th Galileo’s Science Café at http://capmm.gmu.edu/galileo-sciencecafe



“Personalized Therapy: Offering New Hope for Metastatic Breast Cancer Patients”

by Dr. Mariaelena Pierobon
​Precision medicine is transforming cancer therapy om a one-size-fits-all approach to customized patient treatment. Changes within DNA, RNA, and proteins are the underlying cause of cancer and such changes can vary widely across patient populations. By targeting the unique biochemistry of individual tumors, precision medicine provides personalized solutions for each patient.

The SideOut Foundation, a non-profit organization located in Fairfax VA, pioneered the field of personalized treatment for metastatic breast cancer by sponsoring a series of clinical trials in which data collected from each patient’s tumor is used to guide individual treatment selection. Nationwide breast cancer oncologists are working side-by-side with research scientists in the SideOut clinical study to identify genomic and proteomic alterations that are driving tumor growth in each individual patient. The physicians use the molecular information as a roadmap for treatment selection.

I will provide an overview of the SideOut Foundation sponsored trials, the role that our laboratory has played in the delivery of personalized therapy for metastatic breast cancer patients and the tremendous impact precision medicine has on cancer treatment and survival.

Also hear perspective from a patient who participated in the SideOut Trial.

Program Sponsors: ATCC<https://www.atcc.org/> and Prince William County Department of Economic Development<http://www.pwcecondev.org/>

Agenda:
7:00pm-7:15pm-Opening Remarks
7:15pm-7:45pm- Science seminar
7:45pm-8:00pm-Q&A
8:00pm-8:30pm-Networking Reception

[cid:image001.jpg@01D217ED.E1D92C80]
​

--
Amy J. Adams
Scientific Outreach and Education Program Manager
George Mason University
Center for Applied Proteomics and Molecular Medicine
10920 George Mason Circle,
Institute for Advanced Biomedical Research Room 2043, MS1A9
Manassas, VA 20110
Phone:(703) 993-2672<tel:%28703%29%20993-2672>; Email: [log in to unmask]<mailto:[log in to unmask]>

[Image removed by sender. http://capmm.gmu.edu/galileo-sciencecafe]<http://capmm.gmu.edu/galileo-sciencecafe>


Claudia Borke
Academic Advisor
Volgenau School of Engineering, Department of Bioengineering
3904 Nguyen Engineering Building, 1J7
4400 University Drive
Fairfax, VA 22030
Phone: (703) 993-4190
Fax: (703) 993-2077

STUDENTS: Please use your MasonLive e-mail. Include name and G number!





ATOM RSS1 RSS2